$175 Million is the total value of Knoll Capital Management, LLC's 41 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 9.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BHVN | Biohaven Pharmactl Hldg Co L | $131,406,000 | +23.0% | 900,844 | 0.0% | 75.00% | +11.9% | |
| ALDX | Buy | Aldeyra Therapeutics Inc | $5,995,000 | +77.6% | 1,502,460 | +97.8% | 3.42% | +61.5% |
| EIGR | Eiger Biopharmaceuticals Inc | $4,374,000 | -24.1% | 694,232 | 0.0% | 2.50% | -30.9% | |
| ENTX | Entera Bio Ltd | $3,304,000 | -53.7% | 2,484,275 | 0.0% | 1.89% | -57.9% | |
| ORGS | Orgenesis, Inc. | $3,186,000 | -30.3% | 1,316,364 | 0.0% | 1.82% | -36.6% | |
| New | Anavex Life Sciences Corp | $2,110,000 | – | 210,789 | +100.0% | 1.20% | – | |
| ALT | Altimmune Inc | $1,556,000 | +92.1% | 132,978 | 0.0% | 0.89% | +74.8% | |
| BX | Blackstone Group LP | $1,461,000 | -27.2% | 16,000 | 0.0% | 0.83% | -33.8% | |
| CVS | CVS Health Corp | $1,344,000 | -7.9% | 14,500 | 0.0% | 0.77% | -16.3% | |
| ANET | Arista Networks Inc | $1,294,000 | -32.5% | 13,800 | 0.0% | 0.74% | -38.6% | |
| CRBP | Corbus Pharmaceuticals HLDGS | $1,273,000 | -52.6% | 5,045,870 | 0.0% | 0.73% | -56.9% | |
| BAH | Booz Allen Hamilton HLDG CORcl a | $1,175,000 | +2.9% | 13,000 | 0.0% | 0.67% | -6.4% | |
| TMO | Thermo Fischer Scientific Inc | $1,141,000 | -8.0% | 2,100 | 0.0% | 0.65% | -16.3% | |
| LUMN | Lumen Technologies Inc | $1,091,000 | -3.2% | 100,000 | 0.0% | 0.62% | -11.9% | |
| APLT | Applied Therapeutics Inc | $1,026,000 | -55.1% | 1,082,123 | 0.0% | 0.59% | -59.1% | |
| EQX | Buy | EQUINOX GOLD CORP | $971,000 | +158.2% | 99,000 | +117.6% | 0.55% | +134.7% |
| V | Visa | $955,000 | -11.1% | 4,850 | 0.0% | 0.54% | -19.1% | |
| MO | Altria Group Inc | $948,000 | -20.1% | 22,700 | 0.0% | 0.54% | -27.3% | |
| SILV | Buy | SILVERCREST METALS INC | $861,000 | +101.2% | 100,000 | +108.3% | 0.49% | +82.5% |
| PAAS | Buy | PAN AMERN SILVER CORP | $849,000 | +90.8% | 29,500 | +81.0% | 0.48% | +73.8% |
| GLW | Corning Inc | $838,000 | -14.7% | 26,600 | 0.0% | 0.48% | -22.4% | |
| MMX | Buy | MAVERIX METALS INC | $718,000 | +30.1% | 165,000 | +43.5% | 0.41% | +18.5% |
| AEM | AGNICO EAGLE MINES LTD | $704,000 | -25.3% | 15,393 | 0.0% | 0.40% | -32.1% | |
| OSK | OSHKOSH CORP | $694,000 | -18.4% | 8,450 | 0.0% | 0.40% | -25.7% | |
| OR | Buy | OSISKO GOLD ROYALTIES LTD | $676,000 | +10.5% | 235,000 | +23.7% | 0.39% | +0.5% |
| FNV | Buy | FRANCO NEV CORP | $645,000 | +7.9% | 4,900 | +30.7% | 0.37% | -1.9% |
| AMD | Advanced Micro Devices Inc | $627,000 | -30.1% | 8,200 | 0.0% | 0.36% | -36.4% | |
| ASML | ASML Holdings | $609,000 | -28.8% | 1,280 | 0.0% | 0.35% | -35.2% | |
| WPM | New | Wheaton Precious metals | $594,000 | – | 16,500 | +100.0% | 0.34% | – |
| MAG | Sell | MAG SILVER CORP | $584,000 | +65.9% | 17,300 | -20.5% | 0.33% | +50.7% |
| ABEO | Abeona Therapeutics Inc | $461,000 | -35.0% | 2,215,740 | 0.0% | 0.26% | -40.9% | |
| SA | SEABRIDGE GOLD INC | $398,000 | -32.8% | 32,000 | 0.0% | 0.23% | -39.0% | |
| MRTX | Mirati Therapeutics, Inc | $336,000 | -18.2% | 5,000 | 0.0% | 0.19% | -25.6% | |
| Context Therapeutics Ins | $296,000 | -2.3% | 139,520 | 0.0% | 0.17% | -11.1% | ||
| SNGX | Soligenix Inc. | $163,000 | -17.7% | 271,580 | 0.0% | 0.09% | -25.0% | |
| ANVS | Annovis Bio Inc | $161,000 | -15.3% | 14,210 | 0.0% | 0.09% | -22.7% | |
| BTAI | Bioxcel Therapeutics Inc | $92,000 | -78.0% | 20,000 | 0.0% | 0.05% | -79.8% | |
| ORMP | Oramed Pharmaceuticals Inc | $92,000 | -46.8% | 20,000 | 0.0% | 0.05% | -51.4% | |
| AGTC | Applied Genetic Technologies | $77,000 | -28.0% | 100,000 | 0.0% | 0.04% | -34.3% | |
| ANGN | Angion BioMedica Corp | $68,000 | -46.5% | 60,000 | 0.0% | 0.04% | -51.2% | |
| SPRO | Spero Therapeutics Inc | $52,000 | -91.5% | 70,000 | 0.0% | 0.03% | -92.1% | |
| AG | Exit | FIRST MAJESTIC silver corp | $0 | – | -33,000 | -100.0% | -0.27% | – |
| AVXL | Exit | Anavex Life Sciences Corp | $0 | – | -210,789 | -100.0% | -1.63% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Aldeyra Therapeutics Inc | 35 | Q3 2023 | 31.6% |
| Corbus Pharmaceuticals HLDGS | 30 | Q3 2022 | 46.5% |
| Abeona Therapeutics Inc | 30 | Q3 2022 | 34.8% |
| Biohaven Pharmactl Hldg Co L | 26 | Q3 2023 | 79.6% |
| Entera Bio Ltd | 22 | Q3 2023 | 7.8% |
| Ampio Pharmaceuticals Inc. | 21 | Q2 2018 | 11.0% |
| Soligenix Inc. | 20 | Q3 2022 | 1.7% |
| Eiger Biopharmaceuticals Inc | 19 | Q3 2022 | 5.8% |
| Applied Therapeutics Inc | 18 | Q3 2023 | 19.7% |
| Alcobra Ltd | 18 | Q3 2017 | 6.5% |
View Knoll Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| HOOKIPA Pharma Inc. | June 20, 2023 | 5,517,385 | 6.8% |
| Applied Therapeutics Inc. | January 23, 2023 | 3,450,000 | 7.2% |
| Orgenesis Inc. | August 14, 2020 | 1,316,364 | 5.9% |
| Corbus Pharmaceuticals Holdings, Inc. | February 14, 2020 | 5,045,870 | 7.1% |
| ABEONA THERAPEUTICS INC. | February 14, 2018 | 2,359,767 | 5.0% |
| SOLIGENIX, INC. | November 13, 2017 | 870,000 | 9.9% |
| ABEONA THERAPEUTICS INC. | February 14, 2017 | 2,359,767 | 5.9% |
| ALCOBRA LTD. | February 14, 2017 | 1,205,498 | 4.4% |
| Ampio Pharmaceuticals, Inc. | February 14, 2017 | 2,738,322 | 4.8% |
| RITTER PHARMACEUTICALS INC | February 14, 2017 | 952,434 | 8.2% |
View Knoll Capital Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-01-16 |
| 13F-HR | 2023-11-14 |
| SC 13G | 2023-10-04 |
| 13F-HR | 2023-08-15 |
| SC 13G | 2023-06-20 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| SC 13G | 2023-01-23 |
| 13F-HR | 2022-11-14 |
View Knoll Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.